Acclaro Medical Raises $23M in Series B Funding

| Posted on |

Here’s the information extracted from the provided content:

Company Information

  • Startup: Acclaro Medical
  • Founders: Helen Fang (CEO)
  • Focus: Medical technology solutions for patient care and medical practices

Fundraising Details

  • Funding Series: Series B
  • Amount Raised: $23M
  • Date: 29/05/2025

Investors

  • Lead Investor: Accelmed Partners
  • Other Investor: 3E Bioventures Capital (existing investor)

Purpose of Funds

  • Accelerate growth of flagship products (UltraClear and AuraLux)
  • Expedite global market expansion
  • Advance development of new products in the pipeline

Product Information

  • Flagship Product: UltraClear
  • Description: A cold, ablative fiber laser platform for painless anti-aging treatments.

Feel free to ask if you need more information!

Source link

2025-05-29 15:09:53